Development of glioblastoma and blood-tumour barrier models for investigating the combination therapy of anticancer agents and efflux pump inhibitors

Funder	European Commission
Recipient Organization	Universita Degli Studi Di Torino
Country	Italy
Start Date	Jan 01, 2025
End Date	Dec 31, 2026
Duration	729 days
Number of Grantees	1
Roles	Coordinator
Data Source	European Commission
Grant ID	`101151942`

Glioblastoma (GBM) remains the most common malignant primary brain tumour with a median survival

Universita Degli Studi Di Torino

Complete our application form to express your interest and we'll guide you through the process.

Start Year 2025

End Year 2026

Grantees 1